[Federal Register Volume 60, Number 206 (Wednesday, October 25, 1995)]
[Notices]
[Pages 54707-54708]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-26447]



-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on August 16, 1995, Eli Lilly 
Industries, Inc., Chemical Plant, Kilometer 146.7, State Road 2, 
Mayaguez, Puerto Rico 00680, made written request to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the Schedule II controlled substance 
Dextropropoxyphene, bulk (non-dosage forms) (9273).
    The firm plans to manufacture bulk product for distribution to its 
customers.

[[Page 54708]]

    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed to the Deputy 
Assistant Administrator, Office of Diversion Control, Drug Enforcement 
Administration, United States Department of Justice, Washington, D.C. 
20537, Attention: DEA Federal Register Representative (CCR), and must 
be filed no later than December 26, 1995.

    Dated: October 19, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 95-26447 Filed 10-24-95; 8:45 am]
BILLING CODE 4410-09-M